You have 9 free searches left this month | for more free features.

Condition

Advanced Non-Small Cell Lung Cancer (1)

Non-Small Cell Lung Cancer (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

BioNTech SE (1)

Regeneron Pharmaceuticals (1)

Collaborator

BioNTech SE (1)

Intervention

bnt116 (2)

cemiplimab (2)

docetaxel (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

bnt116

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Advanced NSCLC Trial (BNT116, Cemiplimab)

Not yet recruiting

Advanced Non-Small Cell Lung Cancer

BNT116
Cemiplimab

(no location specified)

Jan 3, 2023

NSCLC Trial in Budapest, Gyongyos (BNT116, Cemiplimab, Docetaxel)

Recruiting

Non-Small Cell Lung Cancer

BNT116
+2 more

Baltimore, Maryland
+14 more

Dec 19, 2022